Community Translations
-
Community Translations
Pertuzumab in neoadjuvant treatment of HER2-positive early breast cancer
Pertuzumab injection was granted accelerated approval by the US Food and Drug Administration last fall for use in combination with trastuzumab...
How We Do It
-
How We Do It
Implementation of an oncology exercise and wellness rehabilitation program to enhance survivorship: the Beaumont Health System experience
We developed a multidisciplinary approach to oncology rehabilitation by setting up a physical therapy screening program in a dedicated...
Original Report
-
Original Report
End-of-life home care utilization and costs in patients with advanced colorectal cancer
-
Original Report
An analysis of the variability of breakthrough pain intensity in patients with cancer
Background The management of breakthrough pain in patients with cancer (BTPc) generally includes an initial titration of breakthrough pain...
Reviews
-
Reviews
Current therapeutic options in hairy cell leukemia
Hairy cell leukemia (HCL) is a B-cell chronic lymphoproliferative disorder that was initially described as leukemic reticuloendotheliosis. The...
From the Editor
-
From the Editor
From our pages to your practice
We have some interesting and insightful articles lined up for you this month, beginning with a Commentary by Samuel and Stone on treating HER2-...
Case Reports
-
Case Reports
Delayed response in ipilimumab therapy